The abstract is read at the publisher; the summary is JClub's.
Recombinant BMP3 prevents and reverses pulmonary arterial hypertension in mice, and lung-targeted AAV1-BMP3 overexpression reverses remodeling and improves cardiac function in mice and rats.
- Why it matters: BMP signalling dysregulation is central to PAH, yet key modulators remain unclear, limiting therapeutic targeting of the pathway.
- What they did: BMP3 expression was measured in experimental pulmonary hypertension, pulmonary vascular cells, and plasma from PAH patients; Bmp3-deficient mice and in vitro hPASMCs/hPAECs were tested, with recombinant BMP3 and AAV1-BMP3 used for in vivo overexpression.
- The result: BMP3 is predominantly in PASMCs and is consistently downregulated in experimental and human PAH; PASMC-derived BMP3 inhibits PAEC migration and proliferation, and Bmp3 loss exacerbates PAH in middle-aged mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.